The US government has reopened following its longest-ever shutdown, setting the stage for the eventual release of the gold-standard federal data that is crucial in analyzing the health and trajectory ...

Most start-ups wouldn’t employ the strategy that PostEra has. In fact, many of its business decisions seem counterintuitive. PostEra owns little to no intellectual property (IP) on its early work, ...

The latest trends and issues around the use of open source software in the enterprise. This is a guest post for Computer Weekly Open Source Insider written by Anil Inamdar in his capacity as global ...

Scripts, data, and replication materials for "A study of gender and regional differences in scientific mobility and immobility among researchers identified as potentially talented" This repository ...

Jeremy has more than 2100 published articles on Collider to his name, and has been writing for the site since February 2022. He's an omnivore when it comes to his movie-watching diet, so will gladly ...

In a first, a scientific conference welcomed paper submissions from any area of science, but with one catch: AI had to do most of the work. Called Agents4Science 2025, the Oct. 22 virtual event ...

In a peer-reviewed analysis, scientists quantify amino acids before and after our “last universal common ancestor.” The last universal common ancestor (LUCA) is the single life form that branched into ...

According to Andrew Ng on Twitter, he discussed open science, open source, and JEPA models with Yann LeCun, highlighting the enduring importance of transparent research practices and collaborative AI ...

Scientists from the Indian Institute of Science (IISc) and Caltech have finally solved a decades-old mystery about how photosynthesis really begins. They discovered why energy inside plants flows down ...

The Trump administration has sharply cut funding for scientific research and eliminated thousands of jobs. We spoke to scientists about the work that was lost. By Alan Burdick By most metrics, 2025 ...

ClearPoint Neuro Inc. (NASDAQ:CLPT) shares are trading higher Wednesday after the company announced results from a Phase I-II clinical study evaluating its ClearPoint Prism Neuro Laser Therapy System.

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...